Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Solazyme Inc. : Solazyme Bunge Renewable Oils Joint Venture Receives Funding Approval from Brazilian Development Bank

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/19/2013 | 01:02am CEST
Solazyme Bunge Renewable Oils Joint Venture Receives Funding Approval from Brazilian Development Bank

BNDES to provide approximately USD $120 million in project financing to support sugar-to-oil production facility in Brazil

South San Francisco, Calif.-- January 16, 2013 - Solazyme, Inc. (NASDAQ: SZYM) ("Solazyme"), a renewable oil and bioproducts company, announced today that Solazyme Bunge Renewable Oils, its joint venture with Bunge Global Innovation LLC, a wholly-owned subsidiary of Bunge Limited (NYSE: BG), has received approval for project financing in the form of a loan from the Brazilian Development Bank (BNDES) of R$245,699,000 (or approximately USD$120 million based on the current exchange rate).  The BNDES funding will support the joint venture's first commercial-scale renewable oil production facility in Brazil, which is being constructed adjacent to Bunge's Moema sugarcane mill in São Paulo state. The 8-year loan will have an average interest rate of approximately 4% per annum.

Rogerio Manso, Chief Commercialization Officer, Solazyme, stated, "Solazyme Bunge Renewable Oils is committed to commercializing innovative tailored oil technology in Brazil. This financing from BNDES highlights the significant value that the joint venture can bring to the Brazilian economy."

The project was selected by the PAISS program, a BNDES/FINEP joint plan for stimulating industrial technological innovation in the sugar-based energy and chemical sectors. The funding is mostly provided through the BNDES PSI program (BNDES Investment Support Program) created for stimulating the production, acquisition and export of capital goods and technological innovation. Solazyme Bunge Renewable Oils broke ground in June 2012 and is scheduled to be operational in the fourth quarter of 2013. It will service the renewable chemical and fuel industries within the Brazilian marketplace and will initially target 100,000 metric tons per year of renewable oil production. In November 2012, Solazyme and Bunge announced in a framework agreement that they intend to expand production capacity from 100,000 metric tons to 300,000 metric tons globally by 2016, and that the portfolio of oils will broaden to include a range of healthy and nutritious edible food oils for sale in Brazil.

###

About Solazyme, Inc.

Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme's renewable products can replace or enhance oils derived from the world's three existing sources - petroleum, plants and animal fats.  Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.

Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.

About Bunge Global Innovation LLC

Bunge Global Innovation is an interdisciplinary team applying the latest thinking and technologies to drive innovation across all Bunge business segments.  Its mission is to scout, develop, buy, sell or license technologies that will improve Bunge's sustainability, profitability and competitive advantage.

About Bunge Limited

Bunge Limited (www.bunge.com, NYSE: BG) is a leading global agribusiness and food company operating in over 40 countries with approximately 35,000 employees. . Bunge buys, sells, stores and transports oilseeds and grains to serve customers worldwide; processes oilseeds to make protein meal for animal feed and edible oil products for commercial customers and consumers; produces sugar and ethanol from sugarcane; mills wheat, corn and rice to make ingredients used by food companies; and sells fertilizer in South America.  Founded in 1818, the company is headquartered in White Plains, New York.

Forward Looking Statements

This press release contains certain forward-looking statements about Solazyme, including statements that involve risks and uncertainties concerning: its ability to finalize the BNDES loan; the nature of the final terms of that loan; the ability of the Solazyme Bunge joint venture to draw-down all or any funds from that loan; the ability of the Moema plant to produce tailored oils; the character of the oils produced at that plant; the value of such oils; the value that Solazyme's technology can bring to the Brazilian economy; the timing of the commencement of operations at the Moema plant; the eventual capacity of such plant; the oils that will be produced at the plant and the industries and jurisdictions it will supply; eventual manufacturing capacity expansion by Solazyme and Bunge; the timing of any such expansion; and Solazyme's ability to maintain its relationships with its partners.  When used in this press release, the words "will", "expects", "intends" and other similar expressions and any other statements that are not historical facts are intended to identify those assertions as forward-looking statements.  Any such statement may be influenced by a variety of factors, many of which are beyond the control of Solazyme, that could cause actual outcomes and results to be materially different from those projected, described, expressed or implied in this press release due to a number of risks and uncertainties.  Potential risks and uncertainties include, among others: Solazyme's limited operating history; its limited history in commercializing products; implementation risk in deploying new technologies; its limited experience in constructing and operating commercial manufacturing facilities; delays or inability to construct or start-up production facilities, including those associated with delay or inability to acquire the facility site; its access to adequate supply of feedstock on favorable terms; its ability to manage operational costs at production facilities; its ability to enter into and maintain strategic collaborations; its ability to obtain requisite regulatory approvals; and its ability to access, on favorable terms, the required financing.  Accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what impact they will have on the results of operations or financial condition of Solazyme.

In addition, please refer to the documents that Solazyme, Inc. files with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q for a discussion of these and other risks.  You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this press release.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
02:13p CANNABIS SCIENCE : Releases the Chronic Pain CBIS Transdermal Patches to Meet the Overwhelming Demand from Self-Medicating Patients Worldwide as it Continues to Expands its California Dispensary Network
02:13p PUPPYSPOT : Launches Free Health Clinics for Breeders
02:11p JETBLUE AIRWAYS : Action Plan to Cut Back Emissions
02:11p HUGO GAMES A/S : New share capital registered no. 34/2017
02:11p COMMERZBANK : #17-23 Listing of Knock out warrant issued by Commerzbank AG
02:11p CARECLOUD : Announces SSAE 16 SOC 1 Cloud Security Compliance
02:11p COMMCREATIVE : Announces Beyond Body as the Newest Factory Mark Gallery Exhibit
02:10p J SAINSBURY : Brits All at Sea on Old Fish Names
02:10p AT&T : Sen. Franken Leads Coalition of Senators in Pressuring Justice Department to Reject AT&T-Time Warner Merger if Harms to Consumers Outweigh Benefits
02:10p AT&T : Sen. Warren Joins Coalition of Senators in Pressuring Justice Department to Reject AT&T-Time Warner Merger if Harms to Consumers Outweigh Benefits
Latest news
Advertisement
Hot News 
15.79%IMAGINATION TECHNOLOGIES : in Takeover Talks
-3.18%NINGBO JOYSON ELECTRONIC : Takata shares plunge, change hands for the first time since Friday
1.29%China's Wanda Knocks Back Speculation on Bonds After Price Drop
2.91%Oil keeps a lid on European shares, Novartis drives health stocks
1.01%GLAXOSMITHKLINE : GSK wins $235 million from Teva in Coreg patent trial
Most Read News
02:48aDJR. JOHNSON : Missouri Sues Drug Firms Over Opioid Marketing -- WSJ
06/21 ALPHABET : Uber CEO Travis Kalanick resigns under investor pressure
01:39a WARREN BUFFETT : Home Capital to get C$2 billion loan from Berkshire Hathaway
05:20a BERNARD ARNAULT : Belgium drops case against business of LVMH chief Arnault
06:54a For thousands of U.S. auto workers, downturn is already here
Most recommended articles
08:03a WORLDPAY : Payment firm Worldpay says can operate via Dutch unit after Brexit
07:47a EXCLUSIVE - CHINA UNICOM COUNTS ALIBABA, TENCENT AMONG INVESTORS IN DRIVE TO RAISE $10 BILLION : sources
07:46a TATA STEEL : Thyssenkrupp plans more cost cuts in industrial solutions
07:44a NESTLE : CEO sees transparency as path to regaining status
07:41a Novartis heart drug success opens up new care option